Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

Birkenstock Holding plc (BIRK)

As of 2026-11-08 · 11/15 boxes filled from SEC filings and market data

Conclusion: WATCH

Conviction low · base case +5% · downside -20% · upside +30%

Section 13's FY Sep 2025 base is 13 months old, so I use the newest company guidance, FY2026 (ending 2026-09-30) adjusted EBITDA of at least €710M, for all three cases and hold today's 10.7x EV/EBITDA multiple. At 2026-06-30 net debt of €1,227.0M and Q3 FY2026 weighted 181.5M shares, that gives about $39.10/share (+4.8%); a 20% EBITDA miss gives about $29.78 (-20.2%), and 20% EBITDA growth gives about $48.43 (+29.8%). The market is not missing the brand quality or the 15% constant-currency growth guide; it is already paying 18.1x P/E and 3.39x EV/Sales, above every named peer on P/E. With the base only modestly above today's price and the long rule failed on the base, this is a watch, not a long or short.

Key numbers

  • Share price: $37.32
  • Market cap: $7.01B
  • Latest financial period: FY Sep 2025 to Sep 30, 2025
  • Revenue (FY Sep 2025): €2.10B
  • EV / EBITDA (FY Sep 2025): 10.7x
  • P/E (FY Sep 2025): 18.1x
  • Price / book: 2.31x

The 15 boxes

  1. ✓ 1. Long-form business notes

    BIRKENSTOCK sells footwear through two channels (B2B and DTC) in three regions (Americas, Europe, APMA), making 100% of its footbeds in Germany; revenue grew from €1.24B in FY2022 to €2.10B in FY2025 and net income from €187.1M to €348.3M (all EUR, fiscal years ended 30 September). Between the oldest 20-F here (dated 2024-01-18, FY2023) and the newest (dated 2025-12-18), the capex story shifted from buying the Arouca component plant and building Pasewalk/Görlitz to a larger programme including the Wittichenau factory (expected operational by end of fiscal 2027) plus the October 2025 purchase of its long-standing Australian distributor. FY2025 operating cash flow was €384.3M against €76.7M capex, with €329.1M cash and €2.72B total equity at 2025-09-30. These sources carry no share price, market cap or any period after FY2025, so no current valuation can be formed from them.

  2. ✓ 2. Competitive advantage

    Birkenstock shows a brand/IP-led advantage: FY2025 (year ended 2025-09-30) gross margin was 59.0% (computed from S28), operating income was €549.5M, and DTC was 38% of revenue, while owned German/Portugal plants and trademark enforcement reinforce quality and brand control. But the sources do not prove durability: competition is fragmented and intense, Asian outsourcers may price more aggressively, and counterfeits/knock-offs attack the brand. The financial read stops at FY2025; these sources contain no later quarterly figures, so a current-scale valuation would be out of date.

  3. ✓ 3. 10-Q takeaways

    The latest quarterly filing is the Q3 FY2026 6-K (quarter ended June 30, 2026, filed August 13, 2026): revenue rose 13% reported / 15% constant currency to €719.5m, adjusted EBITDA €242.5m at a 33.7% margin (down 70 bp), and adjusted net profit €133.6m (+15%) / adjusted EPS €0.74 (+19%), while IFRS net profit fell 15% to €109.6m on €22m of non-recurring, non-cash charges from the accelerated share repurchase and senior-note refinancing. A €230m ASR completed June 30, 2026 cut shares outstanding by 6 million and lifted net leverage to 1.8x from 1.5x, with cash at €693.6m. The only forward numbers given are cost headwinds: tariffs ~70 bp and FX ~120 bp on FY2026 margins. No FY2026 actuals exist yet — the November 3, 2026 release says Q4 and full FY2026 results come on December 10, 2026.

  4. ✓ 4. Corporate governance

    Filled; members read this box.

  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ○ 9. Insider trading interpretation
  10. ○ 10. Earnings-call notes
  11. ○ 11. Impression of the shareholder letter
  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans